Loomis, Sayles & Company
SEM

Loomis, Sayles & Company’s Select Medical SEM Stock Holding History

Loomis, Sayles & Company’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-568,003
Closed -$8.62M – 759
2025
Q2 		$8.62M Buy
568,003
+45,236
+9% +$706K 0.01% 393
2025
Q1 		$8.73M Buy
522,767
+152,342
+41% +$2.8M 0.01% 370
2024
Q4 		$6.98M Sell
370,425
-146,413
-28% -$2.82M 0.01% 399
2024
Q3 		$9.71M Buy
+516,838
New +$9.9M 0.01% 362
2018
Q4 		– Sell
-870
Closed -$9K – 922
2018
Q3 		$9K Hold
870
– – ﹤0.01% 825
2018
Q2 		$9K Hold
870
– – ﹤0.01% 811
2018
Q1 		$8K Buy
+870
New +$8.28K ﹤0.01% 829

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Loomis, Sayles & Company's SEM Position: Q3 2025 in Review

Loomis, Sayles & Company sold out of Select Medical (SEM) in Q3 2025, closing a stake of 568,003 shares — an estimated $8.62M sold.

Loomis, Sayles & Company first reported a position in SEM in Q1 2018 and held it in 7 quarters. The position peaked at $9.71M in Q3 2024. 268 funds tracked by Wall St. Rank hold SEM as of Q3 2025.

  • Loomis, Sayles & Company reported no remaining Select Medical position as of Q3 2025 after selling out during the quarter.
  • Loomis, Sayles & Company sold 568,003 Select Medical shares in Q3 2025, an estimated $8.62M.
  • Loomis, Sayles & Company first reported a position in Select Medical in Q1 2018 and held it in 7 quarters.
  • Loomis, Sayles & Company's Select Medical position peaked at $9.71M in Q3 2024.
  • 268 funds tracked by Wall St. Rank held Select Medical as of Q3 2025.

Based on Loomis, Sayles & Company's 13F filing for Q3 2025, filed 13 Nov 2025.